| Financial Year |
March 31 2023 |
| Monetary Funds |
23,867,133.57 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
13,411,796.48 |
| Advances to Suppliers |
6,327,961.21 |
| Other Receivables |
6,227,782.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,885,767.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,269,413.97 |
| Total Current Assets |
55,989,855.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
707,478,737.41 |
| Fixed Assetes |
1,263,253,133.31 |
| Under-construction Projects |
36,824,515.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
580,110,289.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
30,483,864.93 |
| Deferred Income Tax Assets |
99,030,632.41 |
| Other Non-Current Assets |
6,267,460.84 |
| Sub-Total of Non-Current Assets |
2,784,526,188.15 |
| Total Assets |
2,840,516,043.27 |
| Short-Term Loans |
30,041,868.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
219,984,884.21 |
| Accounts Received In Advance |
1,442,801.40 |
| Employee Compensation Payable |
15,057,220.13 |
| Taxes Payable |
2,195,821.56 |
| Interest Payable |
-- |
| Dividend Payable |
2,363.83 |
| Other payables |
13,789,121.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
166,434,961.47 |
| Other Current Liabilities |
38,227.81 |
| Sub-Total of Current Liabilities |
451,055,345.27 |
| Long-term Loans |
1,034,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,476,718.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,814,250.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,310,776,906.69 |
| Total Liabilities |
1,761,832,251.96 |
| Paid-In Capital(Or Share Stock) |
404,817,686.00 |
| Capital Surplus |
852,239,535.83 |
| Surplus Reserve |
47,228,138.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-238,142,028.56 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,078,683,791.31 |
| Owner's Equity（Stockholder's Equity） |
1,078,683,791.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,840,516,043.27 |
